CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations

CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical…

CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has successfully completed Phase One of its Clinical Decision Support (CDS) tool integration including targeted user testing with its partner Premier Health Group (CSE:PHGI).  Premier Health’s leading Electronic […]

The post CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *